期刊文献+

血管内皮生长因子在膀胱移行细胞癌中的表达及意义

Expression and Prognostic Significance of Vascular Endothelial Cell Growth Factor(VEGF) in Bladder Transitional Cell Carcinoma
下载PDF
导出
摘要 目的:研究血管内皮生长因子(VEGF)在膀胱移行细胞癌中的表达及作用。方法:采用免疫组化S-P法检测45例膀胱移行细胞癌及10例正常膀胱粘膜组织,结合临床和病理资料分析其作用。结果:45例膀胱癌组织中VEGF的阳性表达率为62.22%(28/45),正常膀胱粘膜组织中VEGF均为阴性。在肿瘤中随着病理分级的升高,VEGF表达而增强(Ⅰ级35.2%;Ⅱ级71.43%;Ⅲ级85.71%)。T2~T4期的VEGF表达(79.17%)较Tis^T1期(42.86%)两者间有明显差异(P<0.05)。结论:VEGF蛋白在膀胱癌中的表达与膀胱癌细胞的分化程度有关系,可作为判断膀胱移行细胞癌预后的参考指标。 Objective: To study the expression and prognostic significance of VEGF in bladder transitional cell carcinoma(BTCC). Methods:Imrnunohistochemistry was used to detect the expression of VEGF in BTCC(n= 45) and normal bladder mucosa(n=10). Effect was analyzed by both clinical and pathologic data. Results: The positive expression of VEGF in BTCC was 62. 22%(28/45) ,and normal bladder mucosa had no expression. The expression of VEGF was increased with the pathologic grade(grade Ⅰ 35. 2%, grade Ⅱ 71.43 %, grade Ⅲ 85. 71%). There was signifcante difference in the expression of VEGF between grade T2-T4 (79. 17%) and Tis- T1 (42.86%) (P〈0. 05). Conclusion.The expression of VEGF in BTCC is related to the cell differentiation, and it can be a marker of determining prognosis of BTCC.
出处 《医学理论与实践》 2007年第10期1135-1137,共3页 The Journal of Medical Theory and Practice
关键词 膀胱肿瘤 VEGF 免疫组织化学 预后 Bladder neoplasms, VEGF, Immunohistochemistry, Prognosis
  • 相关文献

参考文献7

  • 1Thaloor D, Singh AK, Sidhu GS, et al. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin[J]. Cell Growth Differ, 1998,9(4) : 305-312.
  • 2Cao Y. Therapeutic potentials of angiostatin in the treatment of cancer[J]. Haematologica, 1999, 84 (7) : 643-650.
  • 3Dvorak H, Brown L, Detmar M, et al. Vascular permeability factor vascular endothelia growth factor, factor, microvaseular hyperpermeability, and angiogenesis[J].Am J Pathol, 1995, 146 (2):1029-1035.
  • 4Campbell SC, Volpert OV, Ivanovich M, et al. Molecular mediators of angiogenesis in bladder cancer[J]. Cancer Ras, 1998,58 (6) : 1298-1304.
  • 5Yang CC, Hu KC, Yeh WM. The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression [J]. Urol Oncol, 2004, 22 (1):1-6.
  • 6Santos L, Costa C, Pereira S, et al. Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours[J]. Ann Oncol, 2003,14(9) : 1419-1424.
  • 7Chow NH, Lir HS,Chan SH, et al. Expression of vascular endothelial growth factor in primary superficial bladder cancer[J].Anticancer Res, 1999,19 (5c) : 4593-4597.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部